Ophthalmic Surgery News
-
Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion
Global phase III QUASAR study will assess the efficacy and safety of aflibercept 8 mg in macular edema secondary to retinal vein occlusion (RVO) Study comes after positive data from the phase III PULSAR trial in neovascular (wet) age-related macular degeneration (nAMD) and phase II/III PHOTON trial in diabetic macular edema (DME) QUASAR is expected to enroll around 800 patients in 27 ...
By Bayer AG
-
CO2 fractional laser in cosmetic dermatology
The best CO2 fractional laser machine is a common cosmetic treatment, commonly used for skin treatment such as mole removal, flat warts, acne pit scars, etc. It can also be used for facial rejuvenation such as wrinkle removal, etc. CO2 laser skin resurfacing machine is a minimally invasive laser treatment technique. Traditional CO2 laser treatment has a long recovery period and greater damage, ...
-
Is the CO2 fractional laser damaging to the skin
The best fractional CO2 laser machine is a minimally invasive treatment. It works by heating the dermis and epidermis with a fractional laser, causing microscopic columnar damage to the skin, activating fibroblasts, stimulating collagen remodelling reactions, thickening the dermis and achieving cosmetic results such as wrinkle reduction, skin rejuvenation and spot removal. Today the CO2 laser ...
-
An Easy, Predictable, and Simpler Way to Embolize Tumors
Instylla is now enrolling patients in a clinical trial for the world’s first hydrogel-based liquid embolic intended for the treatment of hypervascular tumors. A second initial application for its Embrace embolic therapy is hemorrhage control, where the product offers advantages in terms of simplicity, speed, and safety. Amar Sawhney and his teams, it seems, can make medical hydrogels do ...
-
Positive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that clinical data from multiple internal and partnered programs were presented at the recent 2022 Annual Meeting of the American Academy of Ophthalmology (AAO), the world's largest association of eye ...
-
Lattice Medical announces the closing of a €8 million Series A financing round
LATTICE MEDICAL, announces the closing of a second round of financing of 8 million euros. This round was led by the historical funds Finovam Gestion, Nord France Amorçage and WiSEED alongside the Captech Santé fund. The European Commission, via its EIC Fund, and Santelys are co-investing. The financing round is completed by non-dilutive financing, in the form of a grant and debt ...
-
Clearside Biomedical to Present Corporate Overview and Upcoming Catalysts at Eyecelerator at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present a corporate overview at the Eyecelerator conference on September 29, 2022, as part of the Annual ...
-
CCRO Conducts First Clinical Trial with Head and Neck Surgery
Jeremy Richmon, MD is leading a new clinical trial sponsored by Alume, the Center for Clinical Research Operations' (CCRO) first clinical trial with Head and Neck Surgery. The trial involves using a tracer to help identify nerves intraoperatively. This type of cutting edge translational surgical innovation improves outcomes and ultimately the lives of our patients. The amount of coordination and ...
-
Senstech AG becomes part of the IST Group
Senstech sensors can be found in a variety of applications in the medical field, such as infusion or insulin pumps, in cardiotocography or in devices for eye surgery. Other important areas of application are textile machinery, mechanical engineering, the watch industry, industrial pressure measurement technology, and applications for cars. In addition to OEM sensor solutions the company also ...
-
Prof. Dr med. Marc Schargus presents a pooled meta-analysis on MINIject at DOC 2022
A meta-analysis from the STAR-I, STAR-II and STAR-III trials on MINIject® was presented at the 34th International Congress of German Ophthalmic Surgeons (DOC) by Prof. Dr med. Marc Schargus (Asklepios Klinik Nord, Hamburg). It was entitled, “Patients with Open Angle Glaucoma Who Consistently Achieve Low Intraocular Pressures (≤18 mmHg) up to Two-years after Implantation with ...
-
Onlume Receives FDA 510(k) Clearance for Fluorescence-guided Surgery Device
OnLume has received 510(k) clearance from the U.S. Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...
By OnLume Inc.
-
iSTAR Medical to attend the 34th International Congress of German Ophthalmic Surgeons (DOC)
We will be in Nuremberg next week at the DOC congress where Prof. Dr med. Marc Schargus (Asklepios Klinik Nord, Hamburg) will be presenting a meta-analysis from the STAR-I, STAR-II and STAR-III trials on patients with open-angle glaucoma who consistently achieve low diurnal intraocular pressures (IOP) of ≤18 mmHg up to two-years after implantation with MINIject. The Advanced Glaucoma ...
-
The Bevan Commission Launches the Planned Care Innovation Programme
Responding to the urgent challenges presented by Covid-19, the Planned Care Innovation Programme is supporting people working in the health and care sector to take forward innovative ideas, opportunities, and ways of working to improve planned care services across Wales. Led by the Bevan Commission, Wales’ leading health and care think tank (hosted and supported by Swansea University), in ...
By MediWales
-
3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial
3DBio Therapeutics (3DBio), a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant, an investigational, patient-matched, 3D-bioprinted living tissue ear implant. The groundbreaking reconstructive procedure in the first-in-human Phase 1/2a clinical trial is ...
-
Sight Sciences’ OMNI® Surgical System Reduces IOP, Daily Fluctuations in IOP and Medication Use, as Shown in Newly Published 12-Month Clinical Datagrafic lines 4 Sight Sciences’ OMNI® Surgical System Redu
Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives, today announced publication in Clinical Ophthalmology of its 12-month outcomes in the GEMINI study, including results from a Hispanic population subset. The final study results demonstrated that canaloplasty ...
-
BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421 for Dry Eye Syndrome
BRIM Biotechnology, Inc. (“BRIM”) a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. (“ORA”) the world’s leading, ophthalmic research organization, for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM ...
-
CMR Surgical & Surgical Innovations develop new surgical hybrid port access system
CMR Surgical & Surgical Innovations develop new surgical hybrid port access system Surgical Innovations’ new YelloPort Elite™ 5mm, with reusable trocar and canula, reduces cost and waste generated when compared with traditional fully single use Port Access Systems Developed with CMR Surgical, the port access system is the latest addition to Surgical Innovation’s ...
-
Autocam Medical Recruiting for High-Paying Careers at MCC Job Fair
Autocam Medical, a global contract manufacturer of precision surgical and medical components and devices, announced Tuesday that they would be recruiting for a number of positions at the Montcalm Community College Job Fair on March 22nd. The company is looking to hire CNC Machinists, Manufacturing Engineers, and Secondary Operators that aspire to become Machinists. While the event is being held ...
-
FDA clears Sonavex’s ultrasound blood flow monitor
Sonavex scored FDA clearance for its technology that uses ultrasound imaging and deep learning to deliver blood flow data on demand. The EchoSure system is cleared for use with the company’s EchoMark bioresorbable tissue markers, which got the agency’s nod in June. “The key goal is to be able to detect the problems associated with microvascular and vascular surgeries with ...
-
Sight Sciences Launches “Don’t Wait for Too Late” Awareness Campaign for Glaucoma
Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced the launch of its “Don’t Wait for Too Late” educational campaign designed to raise awareness among the optometric community of minimally invasive glaucoma surgery (MIGS) as an ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you